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ABSTRACT 
We present a case of a postmenopausal woman diagnosed with an ovarian 
mass containing thyroid follicles and foci of papillary thyroid carcinoma 
during pathological examination. This patient referred having had a 
metachronous thyroid malignancy 10 years before. The differential diagnosis 
between a thyroid malignancy arising from a struma ovarii and a metastatic 
ovarian tumor originating from thyroid-cancer is challenging. Struma ovarii 
should be considered when thyroid components are the predominant element 
or when thyroid malignant tissue is identified within an ovarian lesion. 
Thyroid carcinoma arising from a struma ovarii is reported to occur in a 
minority of cases. Of these, papillary carcinoma is the most frequent subtype 
encountered. Regarding primary thyroid carcinomas, papillary carcinomas 
have a lower metastatic potential when compared to follicular carcinomas, 
and most of the metastases occur in the cervical lymph nodes. Ovarian 
metastases are exceedingly rare and generally associated with widespread 
disease. However, they must be considered in the presence of previous 
history of malignant thyroid carcinoma. The authors review the main clinical, 
imaging and therapeutic aspects of both these entities and present the most 
likely diagnosis. 
 
CASE REPORT 
 
 
  
 
A 78-year-old woman complaining of pelvic pain and 
significant weight loss was referred for gynecological 
examination.  
 
Her medical history was positive for multinodular goiter. 
A partial left thyroidectomy had been performed ten years 
before, after a tumor measuring 8x5x4,5cm was diagnosed. 
Although the latter was initially thought to be a follicular 
adenoma, a subsequent reassessment was performed at our 
institution and the microscopic findings were considered to be 
a follicular variant of a papillary thyroid carcinoma.  No 
therapy was further purposed and the thyroid ultrasounds 
performed periodically thereafter revealed no significant 
variation in size of the multiple nodules detected. The latter 
measured up to 1.5cm in greatest axis and presented either a 
mixed solid and cystic and a predominantly cystic nature (fig. 
1). There was  no history of either benign or malignant thyroid 
disease in the patient's family. 
 
During physical examination, a large mass was found on 
the right lower quadrant of the abdomen. 
 
The routine laboratory data, the serum level of CA-125 
and the levels of circulating thyroid hormones - thyroid 
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25 
stimulating hormone (TSH), free T4 and thyroglobulin, were 
within the normal range. 
 
Pelvic transabdominal ultrasound revealed a partially 
solid and cystic mass in the right adnexal area, measuring 
8x7,9x7,2cm (fig. 2A). The identification of both thick 
septations and solid well-vascularized components raised the 
suspicion for an ovarian malignancy (figs. 2B and 2C). A 
pelvic MR imaging was subsequently performed (fig. 3) and 
revealed a predominantly multiloculated mass presenting 
thickened septa and a variable signal intensity between locules 
("stained glass appearance"). Some of these locules showed 
low signal intensity on both T1- and T2-weighted images (figs. 
3A and 3B; white asterisk), while others exhibited low signal 
intensity on T1-weighted images and high signal intensity on 
T2-weighted images (figs. 3C and 3D; white arrow). The 
lesion had also solid components (figs. 3A and B; white-
bordered arrow), which presented intermediate to low signal 
on both T2- and T1-weighted images.  The presence of signal 
voids within the latter (figs. 3A and B; thin white arrow) and 
the visualization of numerous perilesional vessels nourishing 
the tumor reflected its hypervascular nature (figs. 4A and 4B; 
white arrow). Nonetheless, further evaluation with gadolinium 
administrated was not possible upon patient refusal. No fatty 
components within the lesion were detected on the fat-
saturation T2-weighted images (figs. 3B and 3D). A small 
amount of ascites was additionally detected in the pouch of 
Douglas / cul-de-sac (figs. 3B and 4B; black asterisk). 
 
The patient underwent a right salpingo-oophorectomy 
with no postoperative complications. The right ovary 
measured 10x9x5cm and weighted 256g; it was partially 
cystic, with yellow serous fluid and green gelatinous colloid 
material separated by thick septations. During histological 
examination of the tumor, thyroid tissue with follicles of 
variable sizes were detected. A classic pattern of papillary 
thyroid carcinoma was observed, with no signs of vascular 
invasion or ovarian capsule invasion (figs. 5A and 5B). The 
fallopian tube was normal on gross and microscopic 
observation. 
 
The resection of the remaining thyroid was performed 
shortly after and a small focus of papillary thyroid carcinoma 
was detected in the right lobe, surrounded by nodular 
hyperplasia. This tumor was diagnosed as a follicular variant 
of papillary thyroid carcinoma, which, once again had no signs 
of either vascular invasion or extra thyroidal extension (figs. 
6A and 6B).  
 
Although no further treatment with ablative I131 therapy 
was performed, the thyroglobulin levels remained undetectable 
and there was no evidence of local recurrence or metastatic 
disease during short-term follow up. However, the patient 
developed a multiple myeloma during the 2 year follow-up 
period and died shortly after. 
 
 
  
 
Ovarian metastasis of thyroid origin and thyroid 
carcinoma arising from a struma ovarii are the two major 
differential diagnoses that have to be considered when a 
woman with history of metachronous thyroid carcinomas 
presents with an ovarian mass containing thyroid tissue and 
foci of thyroid carcinoma. 
 
Awareness of personal and family history of malignant 
thyroid disease and investigation of thyroid disease through a 
careful physical examination and thyroid ultrasound are 
mandatory to differentiate between these two conditions [1-3].  
 
The diagnosis of ovarian metastasis could not be ruled out 
in this case, since no other teratomatous elements were 
detected in the ovarian mass and because there was a history of 
malignant thyroid disease. However, we believe that a 
papillary thyroid carcinoma arising from a struma ovarii would 
be the most adequate diagnosis, based mainly on three reasons.  
 
First, thyroid malignancy arising from the struma ovarii is 
reported in 5%-10% of cases [4], occurring much more 
commonly than an ovarian metastasis from the thyroid[1, 2]. In 
the past, many authors did not consider ovarian metastasis as a 
differential diagnosis when thyroid tissue was identified in an 
ovarian lesion and other authors dismissed this condition when 
small thyroid primary tumors were detected or when there was 
a long time interval between the occurrence of each tumor [2]. 
 
Second, papillary carcinoma is the malignant subtype 
most frequently arising in the struma ovarii and represents 
70% of all cases, 44% percent of these being classical type and 
the remaining 26% being a follicular variant of papillary 
carcinoma [4, 5]. The concomitant presence of normal thyroid 
epithelial tissue representing the predominant component in 
the ovarian lesion, as described in this clinical case, is highly 
suggestive of struma ovarii origin, even though no other 
teratomatous elements were identified [2]. Some cases of 
thyroid-type carcinoma with no benign struma ovarii 
component have also been described [1]. 
 
Third, ovarian metastases from papillary thyroid 
carcinoma are rare. Papillary carcinomas comprise 80% of 
clinically detected thyroid cancers and are associated with a 
favorable prognosis, due to their low metastatic potential, 
particularly in the absence of extrathyroid or vascular invasion, 
as was detected in this case [6]. Besides, occult papillary 
thyroid microcarcinomas were found in 46 out of 408 (11,3 %) 
thyroid glands during autopsy [7], which suggests that a single 
focus of microcarcinoma in a thyroidectomy specimen may be 
an incidental finding without clinical importance. Most of the 
recurrences of papillary thyroid cancer occur in cervical lymph 
nodes and its incidence is reported in up to 70% of all cases 
[8].  Although distant metastases may occur many years or 
even decades after diagnosis, their prevalence is much lower 
when compared with follicular carcinomas, and both the lung 
and the skeleton are the most common sites involved [3]. Only 
two cases of ovarian metastases with papillary thyroid origin 
were reported so far in the literature; one presenting as 
bilateral ovarian metastases in a patient with autoimmune 
thyroiditis and an aggressive form of primary thyroid 
malignancy [3] and another presenting as   unilateral cystic 
ovarian metastasis in a patient with widespread metastatic 
disease [2]. In the unique case of ovarian metastasis from 
DISCUSSION 
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26 
thyroid carcinoma detected 12 years after partial 
thyroidectomy, the patient also had widespread metastases of a 
follicular subtype tumor [9]. There was no evidence of cervical 
or distant metastatic involvement in our patient, during the 12-
year follow-up period. Additionally, the variation in 
histopathology detected between thyroid and ovarian tumors, 
reduced the likelihood of metastatic involvement [2]. 
 
Struma ovarii was first described in 1895 [10] and 
represents 5% of all ovarian teratomas [4]. It is defined as a 
monodermal variant of ovarian teratomas in which thyroid 
tissue is the predominant (>50%) or exclusive component [1, 
4]. Moreover, it also includes cases of mature cystic teratomas 
with macroscopically identifiable thyroid tissue or containing 
malignant thyroid tissue, even when the thyroid tissue 
component is less than 50% of the lesion [1].  
 
The term malignant struma ovarii should be avoided and 
replaced by thyroid-type carcinoma originating in the struma 
ovarii (specifying the type) to describe this entity, because 
many cases of strumal carcinoid tumors have been 
misdiagnosed and reported as malignant struma ovarii [1]. 
 
Thyroid carcinoma arising in the struma ovarii is more 
likely to occur in lesions larger than 16cm or when peritoneal 
metastatic involvement is identified, the latter being usually 
described as strumosis [9, 11]. It predominantly affects the left 
rather than the right ovary, for unexplained reasons [5]. 
 
The mean age of presentation is similar to other mature 
cystic teratomas and is usually between 40 and 60 years of age 
[1, 4], although some cases have been reported in prepubertal 
and postmenopausal ages [12, 13]. Most patients present with 
pelvic pain or irregular menstrual bleeding [4, 11]. 
Hyperthyroidism is detected in only 5-8% of all cases [4, 5]. 
Its presence, generally caused by an adenoma, may raise the 
suspicion for a functional struma ovarii in the absence of 
goiter [5]. 
 
Ascites has been reported in up to 17% of cases and 
Meigs' syndrome can occasionally occur [4, 13, 14]. However, 
tumor cells are usually not present in the peritoneal fluid [4].  
 
Serum CA125 level may be elevated, but this also occurs 
in association with other germ cell tumors [4]. 
 
There are no imaging specific features for struma ovarii. 
Ultrasound usually reveals a heterogeneous mass with 
predominantly solid and multiple cystic areas, which reflect 
the gross pathologic characteristics of this tumor. The 
visualization of abundant low resistance blood flow within the 
highly vascular central portion of the tumor has been referred 
as a typical finding observed with color/Doppler imaging [14, 
15]. CT imaging usually reveals a multiloculated cystic mass 
with different densities among the locules, as well as solid 
components. In addition, fat and calcifications may be 
occasionally identified within the tumor, the latter being more 
easily detected with this technique rather than with MR 
imaging [10]. Only a few reports of MR imaging findings of 
struma ovarii are described in the literature. A multiloculated 
cystic mass presenting a variable signal intensity among the 
cystic locules ("stained glass appearance") and a strongly 
enhancing solid component is regarded as the classic 
appearance of this entity [16,17]. Locules with very low signal 
on T1- and T2-weighted images usually contain gelatinous 
colloid material, which has a higher viscosity than mucinous 
fluid [16, 17]. The presence of ascites has been also reported 
[4, 10, 14]. 
 
To our knowledge, the imaging appearance of ovarian 
metastases of thyroid origin was never reported in the 
literature. Mature cystic teratomas and mucinous neoplasms, 
either cystadenomas or cystadenocarcinomas, constitute the 
main differential diagnosis of struma ovarii, according to 
imaging findings. However, the radiologist should be aware 
that 50-60% of struma ovarii cases are associated with mature 
cystic teratomas and, in smaller percentages, with mucinous 
cystadenomas and carcinoid tumors [1].  
 
Mature cystic teratomas may resemble struma ovarii on 
ultrasound scans, particularly when they present as a cystic 
lesion with an echogenic solid component (Rokitansky 
nodule). However, in opposition to struma ovarii, the blood 
flow is usually only detected at the periphery of the lesion and 
the Rokitansky nodule is usually avascular; if the presence of 
Doppler color is ever detected, the possibility of malignancy 
transformation should be raised [18, 19]. Mature cystic 
teratomas  can also present as diffuse or partially echogenic 
masses with sound attenuation (reflecting hair or sebaceous 
material content) or as cystic masses with multiple linear 
strands, in relation with the presence of hair [19, 20]. Teeth or 
wall calcifications are described to occur in 56% of cases and 
are best depicted on CT. This technique is also very sensitive 
for the presence of fat, which is reported on 93% of cases ; 
occasionally, a fat-fluid level may be seen within the cystic 
lesion [18]. At MR imaging, the intratumoral fat usually shows 
high signal intensity on T1-weighted images and signal loss on 
fat saturated T1-weighted images. In addition, the chemical 
shift artifact can be particularly helpful in the diagnosis of 
teratomas without demonstrable fat (described as 15% of 
cases), by demonstrating a drop in signal intensity in the out-
of-phase image [20].  
 
Although mucinous tumors usually occur in a different 
age group, being more prevalent in the sixth and seventh 
decades of life, their differentiation from struma ovarii can be 
very difficult at imaging, because both of them most 
commonly present as multiloculated cystic masses containing 
fluid of different attenuation or signal intensity on CT and MR 
imaging, respectively [16, 21]. However, the "stained glass 
appearance" of mucinous tumors is related to different mucin 
concentration: thick mucin shows high signal intensity on T1-
weighted images and low signal intensity on T2-weighted 
images, while watery mucin usually shows high signal intensity 
on T2-weighted images and low signal intensity on T1-
weighted images [21]. A malignant cystadenocarcinoma is 
suspected when solid components or thick and irregular wall 
and septa are identified, in opposite to benign cystadenomas, 
which usually have thin and regular wall and septa [21]. 
Calcifications can be also identified in mucinous tumors and 
were reported to occur in 34,1% of CT scans [22]. 
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A correct pre-operative diagnosis of struma ovarii is only 
possible when I131 scintigraphy is performed, in patients with 
hyperthyroidism and high levels of serum TSH [11].  
 
The majority of patients are diagnosed postoperatively, as 
was the case of our patient. Macroscopically, the tumor is 
typically brown or green-brown, solid or predominantly solid 
and gelatinous. Nonetheless, cystic or predominantly cystic 
multilocular tumors have also been described [1, 4].  
 
Thyroid carcinoma arising in a struma ovarii is reported to 
occur in 5-10% of cases [4]. The morphological criteria of 
these tumors is based on classical criteria for primary thyroid 
carcinomas [1]. The presence of ground glass overlapping 
nuclei, nuclear grooves and papillary architecture are 
diagnostic of papillary carcinomas, which represent the 
majority of thyroid carcinomas arising in struma ovarii. The 
identification of psammoma bodies is also highly suspicious 
[1]. Lesions sharing the same nuclear features but lacking 
papillary architecture represent the follicular variant of 
papillary carcinoma [1]. Follicular carcinoma is encountered in 
30% of cases of thyroid carcinomas arising in struma ovarii 
[5]. Its diagnosis is more difficult, since there is no capsule in 
the ovarian counterpart and evidence of malignancy is only 
suggested by vascular invasion, metastases or invasion into the 
remaining ovarian tissue [1, 4].  A new variant of follicular 
carcinoma named highly differentiated follicular carcinoma of 
ovarian origin, has been recently described [1] and is 
characterized by extraovarian dissemination of thyroid 
elements [4]. 
 
Surgery is mandatory for diagnosis, surgical staging and 
definite treatment [11]. The surgical approach depends on 
patient age, with unilateral salpingo-oophorectomy being 
recommended in younger women in reproductive age and total 
abdominal hysterectomy and bilateral salpingo-oophorectomy 
being performed in postmenopausal women [11]. However, 
the management of struma ovarii cases after surgery is still not 
clearly defined, as it is based on small series review [4]. Some 
authors suggest that the treatment should be similar to its 
thyroid counterpart [23]. Total thyroidectomy is recommended 
to provide effective ablative therapy with I131 and 
levothyrotoxine suppressive therapy. However, other authors 
recommend a similar management as used in other germ cell 
tumors [4]. 
 
The prognosis of thyroid-type carcinoma is unknown, 
owing to its rareness and to the absence of consensus in both 
its diagnosis and treatment. A stratification of malignancy into 
high and low risk patients was suggested [24]. A focus of 
thyroid carcinoma with less than 2 cm is considered as low 
risk, with larger carcinomas, extraovarian disease and 
aggressive histological features being considered as high-risk 
features [4]. However, most cases do not have a clinical 
aggressive course; therefore, the detection of malignancy in 
struma ovarii does not necessarily correlate with biological 
behavior [1].  
Although there are no standard follow-up protocols for 
these patients, a 10-year follow-up is recommended and 
includes thyroglobulin levels assessment or a I131 whole-body 
scan. The average time for recurrence is 4 years and is 
reported in 15% of cases [4]. Metastases are uncommonly seen 
in these patients, occurring in less than 23% of cases [4, 5].  
Follicular carcinoma is more likely to spread to distant organs, 
namely the lung, liver and central nervous system, while 
papillary carcinoma usually extends to the abdominal cavity, 
lymph nodes and, rarely, to the liver [4]. To our knowledge, 
metastatic involvement of the thyroid gland has never been 
reported in the literature. 
 
 
 
 
The awareness of malignant thyroid disease is mandatory when 
thyroid tissue and thyroid-subtype carcinoma are detected 
within an ovarian mass. Two major differential diagnoses must 
be considered: metastatic carcinoma of thyroid origin and 
thyroid carcinoma arising in a struma ovarii. The identification 
of a multiloculated ovarian cystic mass presenting a solid 
component and a variable signal intensity between  locules 
("stained glass appearance") on MR imaging, should raise the 
suspicion of struma ovarii. 
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Figure 1: Thyroid ultrasound. 71-year-old female patient with an ovarian lesion containing thyroid follicles and foci of 
papillary carcinoma, most probably representing a papillary carcinoma arising in a struma ovarii. Ultrasound scans in axial 
(1A) and sagittal (1B) planes depict multiple nodules in the right thyroid lobe, measuring up to 1.5cm in greatest axis, some of 
them being mixed solid and cystic and the others being predominantly cystic. None of the nodules exhibited suggestive 
features of malignancy [GE Voluson V730, linear transducer, 37 Hz].  
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Figure 2: Pelvic transabdominal ultrasound. 71-year-old female patient with an ovarian lesion containing thyroid follicles and 
foci of papillary carcinoma, most probably representing a papillary carcinoma arising in a struma ovarii. A heterogeneous 
complex-appearing right adnexal mass, containing solid and cystic areas, was detected (2A). The presence of several thick 
septations and solid areas within the tumor (2A and 2B), as well as the identification of ascites in the cul de sac (2C) raised the 
suspicion for an ovarian malignant neoplasm. Color Doppler ultrasound revealed flow in the septa and in the solid areas (2B) 
[GE Voluson V730, curved transducer, 10-15 Hz].  
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Figure 3: Pelvic Magnetic Resonance Imaging. 71-year-old female patient with an ovarian lesion containing thyroid follicles 
and foci of papillary carcinoma, most probably representing a papillary carcinoma arising in a struma ovarii. Axial T1-
weighted images (3A and 3C) and T2-weighted images with fat saturation (3B and 3D) revealed a multiloculated cystic mass 
presenting locules with variable signal intensity ("stained glass appearance") and thick septations.  Some locules showed low 
signal intensity on T1-weighted images and high signal intensity on T2-weighted images (white arrow; 3C and 3D), while other 
locules exhibited low signal intensity on both T1- and T2-weighted images (white asterisk; 3A and 3B), the latter most 
probably due to the presence of colloid content. Other areas with intermediate signal on T1- and T2-weighted images (white-
bordered white arrow; 3A and 3B) presented linear signal voids (thin arrow; 3B) within it and were compatible with solid 
areas.. No fatty component was detected. A small amount of ascites was identified in the pouch of Douglas / cul-de-sac (black 
asterisk; 3B) [GE Signa HDe 1.5T: T1-weighted images (TR=420; TE=12,8); T2-weighted images (TR=2380; TE=105); 
Proton-density weighted image (TR= 3560; TE= 38,4)].  
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Figure 4: Pelvic Magnetic Resonance Imaging. 71-year-old female patient with an ovarian lesion containing thyroid follicles 
and foci of papillary carcinoma, most probably representing a papillary carcinoma arising in a struma ovarii. Parasagittal (4A), 
sagittal (4B) and coronal (4C) T2-weighted images, and axial T2-weighted images with fat saturation (4D). Multiple 
serpiginous vessels presenting as signal voids were seen surrounding (thick white arrow; 4A and 4B) and entering the ovarian 
mass (thin white arrow; 3A), thus confirming the rich vascularity of the tumor. The left ovary was atrophic, given the 
postmenopausal age of the patient (black arrow; 4D). A small amount of ascites was detected in the pouch of Douglas / cul-de-
sac (black arrow; 4B) [GE Signa HDe 1.5T: T1-weighted image (TR=420; TE=12,8); T2-weighted images (TR=2380; 
TE=105); Proton-density weighted image (TR=3560; TE=38,4)].  
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Etiology Unknown 
Incidence Struma ovarii: 5% of all ovarian teratomas 
Thyroid-carcinoma arising in struma ovarii: 5-10% 
Papillary carcinoma - 70% (classical subtype - 44%; follicular variant subtype -26%) 
Follicular carcinoma - 30% 
Gender ratio Women 
Age predilection 4th-6th decade 
Risk factors Lesions> 16cm; Strumosis 
Treatment Unilateral or bilateral salpingo-oophorectomy (depending on age) + total thyroidectomy 
Prognosis Still unknown  
Findings on imaging  US - Mixed solid and cystic mass, exhibiting abundant and low resistance flow within the central 
solid component on color Doppler imaging 
 CT - Multiloculated cystic mass presenting fluid with variable density between locules; 
Calcifications may be identified 
 MR - Multiloculated cystic mass presenting fluid with variable signal intensity (“stained glass 
appearance”) among locules and a solid component, which usually displays avid gadolinium 
enhancement. The fatty component is not a common feature, except when it occurs in association 
with mature cystic teratoma. Ascites can be present. 
 NOTE: The diagnosis of malignant thyroid tissue is based on microscopic findings.  
 
Table 1: Summary table of thyroid carcinoma arising in struma ovarii 
 
 
Figure 5: Microscopic examination of hematoxylin and eosin (h&e) stained sections. 71-year-old female patient with an 
ovarian lesion containing thyroid follicles and foci of papillary carcinoma, most probably representing a papillary carcinoma 
arising in a struma ovarii. The ovarian tumor was composed of thyroid follicles and of areas with papillae formation and 
papillary carcinoma nuclear features (5A), best depicted in the high power view (5B). 
 
 
 
Figure 6: Microscopic examination of hematoxylin and eosin (h&e) stained sections . 71-year-old female patient with an 
ovarian lesion containing thyroid follicles and foci of papillary carcinoma, most probably representing a papillary carcinoma 
arising in a struma ovarii. Low and high power views of left thyroid lobe depict an uncapsulated nodule with oncocytic features 
and empty and grooved nuclei, respectively (6A). High power view of the right thyroid lobe shows a papillary carcinoma with 
follicular pattern (6B). 
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 US CT MR 
Struma ovarii  Heterogeneous mass with solid 
and multiple cystic areas  
 Doppler: abundant and low 
resistance flow located centrally 
within the solid component 
 Multiloculated cystic 
mass with variable density 
between locules 
 Calcifications might be 
present 
 Multiloculated cystic mass with variable 
signal intensity between locules on T2WI 
(“stained glass appearance”) 
o Areas of very low signal intensity on 
T1WI and T2WI (colloid material) 
 Solid component with avid enhancement 
on enhanced T1images 
 Presence of fat is not characteristic, unless 
it occurs in association with mature cystic 
teratoma 
 Ascites can be present 
Mucinous tumors 
(mucinous 
cystadenoma or 
cystadenocarcinoma) 
 Complex cystic mass with 
multiple locules showing 
variable echogenicity 
 Multiloculated ovarian 
mass with variable density 
between locules 
 Calcifications might be 
present  
 
 Usually a large multiloculated cystic mass 
with variable signal intensity within 
locules  
 (“stained glass appearance”) 
o Thick mucin (high signal intensity on 
T1W1 and low signal intensity on T2WI)  
o watery mucin (high signal intensity on 
T1W1 and low signal intensity on T2WI) 
 Mucinous cystadenoma: thin regular cystic 
wall and septa; solid vegetations are 
usually not present 
 Mucinous cystadenocarcinoma: thick and 
irregular cystic wall and septa; 
vegetations/soft-tissue component are 
typically seen 
Mature cystic 
teratomas 
 Three types of appearance: 
1. Cystic lesion with an avascular 
and echogenic component 
(Rokitansky nodule) 
2. Diffuse or partially echogenic 
mass with sound attenuation 
(hair or sebaceous material) 
3. Cystic mass with linear 
echogenic strands (hair)  
 Doppler US: blood flow 
detected at the periphery of the 
lesion 
 Cystic lesion with 
concomitant presence of 
fat (+/- fat fluid level)  
 Teeth or wall 
calcifications may be also 
present  
 Cystic mass with fat component 
o High-signal intensity on T1WI 
o Fat-fluid or fluid-fluid level within the 
cystic cavity 
o Chemical-shift artifact useful in teratomas 
without demonstrable fat   
 Teeth or calcifications may also be 
identified 
o Low-signal intensity on T1WI e T2WI  
 Soft-tissue nodule in the cystic wall 
(Rokitansky nodule/dermoid plug)  
o  No contrast enhancement  
 
Table 2: Differential diagnosis of struma ovarii 
CT = Computed Tomography 
MR = Magnetic Resonance  
US = Ultrasound 
 
Urogenital System; Ovarian Neoplasms; Papillary thyroid 
carcinoma; Ovarian metastasis; Struma ovarii; Thyroid 
neoplasms 
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